Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements

Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements

As the trading week nears its conclusion, investors may find it opportune to assess the market landscape and delve into companies that garnered attention during this period. This piece offers insights into five stocks that merit consideration for tracking purposes. 

Dyadic International Inc. (NASDAQ: DYAI) has garnered significant attention from investors over the past month, with its stock showing a 31.91% increase in value within a 30-day period through yesterday. On March 29, Dyadic International Inc. released its financial results for the fiscal year 2023. The company reported revenues of $2,899,000 for the year ended December 31, 2023, a slight decrease the previous fiscal year. However, its net loss for the year decreased to $6.8 million, or $0.24 per share, down from $9.7 million, or $0.34 per share, in the previous year. The company's cash, cash equivalents, and investment-level securities were valued at $7.3 million at the end of the fiscal year. Also, on March 11, 2024, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company's CEO. This infusion has bolstered the company's robust capital position.  See Zacks Small-Cap Research Report, updated April 1, 2024. 

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Although the pullback in the price action in the company’s stock yesterday was interesting, it should be noted that up until April 3, it had clocked gains of 98.82% in 30 days. On March 25, Kaival Brands Innovations Group Inc. announced its financial results for the first fiscal quarter ended on January 31, 2024. The revenues for the quarter went up to $3.2 million from $2.5 million in the year-ago period, and the rise was attributed to the reduction of credits issued to customers. The net loss in the quarter was $2.2 million, which reflected a drop from the net loss of $3 million in the prior year. 

Catheter Precision, Inc. (NYSE-American: VTAK), a prominent player in the medical technology sector, has experienced a surge in its stock value recently, making it an intriguing option for investors to monitor closely. On April 4, Catheter Precision Inc., renowned for its cardiac electrophysiology offerings, announced a significant expansion of its business development team. The company disclosed its strategic move to bolster its sales force by recruiting seasoned industry professionals, aiming to enhance market penetration and drive further growth. Notably, this new team has successfully propelled the sales figures of an electrophysiology products firm beyond the $100 million mark. See Ladenburg Thalmann Report date April 5, 2024.

Nikola (NASDAQ: NKLA) experienced a robust surge in its stock value on Thursday, fueled by a significant development. The uptick followed Nikola's impressive deliveries for the first quarter of 2024, surpassing analysts' expectations. The company delivered 40 vehicles during the quarter, exceeding the consensus estimate of 30 deliveries by four analysts. Nikola's production during this period totaled 43 units, contributing to its positive performance. 

Atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical firm focused on revolutionizing mental health disorder treatments, disclosed its financial performance for the fourth fiscal quarter and the full fiscal year ending December 31, 2023, on March 28. The company reported net losses of $18.3 million and $40.2 million for the respective periods, showcasing a significant improvement compared to the net losses of $45 million and $152.4 million in the prior-year quarter and fiscal year.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.